Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionIntellectus Partners, LLC
Latest Disclosed Ownership1,726 shares
Latest Disclosed Value $ 1,587,732
Intellectus Partners, LLC reports 8.90% increase in ownership of LLY / Eli Lilly and Company

On April 10, 2026 - Intellectus Partners, LLC filed a 13F-HR form disclosing ownership of 1,726 shares of Eli Lilly and Company (US:LLY) valued at $1,587,523 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,585 shares of Eli Lilly and Company. This represents a change in shares of 8.90% during the quarter. The current value of the position is $1,861,974 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F ELI LILLY COM 532457108 1,726 141 8.90 1,588 -6.81 0.3241
2026-02-10 2025-12-31 13F ELI LILLY COM 532457108 1,585 79 5.25 1,703 48.34 0.3291
2025-11-12 2025-09-30 13F ELI LILLY COM 532457108 1,506 87 6.13 1,149 3.80 0.2226
2025-08-05 2025-06-30 13F ELI LILLY COM 532457108 1,419 0 0.00 1,106 -5.55 0.2389
2025-04-11 2025-03-31 13F ELI LILLY COM 532457108 1,419 342 31.75 1,172 40.91 0.2890
2025-02-07 2024-12-31 13F ELI LILLY COM 532457108 1,077 652 153.41 832 121.01 0.1841
2024-11-06 2024-09-30 13F ELI LILLY COM 532457108 425 0 0.00 377 -2.34 0.0963
2024-07-18 2024-06-30 13F ELI LILLY COM 532457108 425 -31 -6.80 385 8.76 0.1051
2024-05-03 2024-03-31 13F ELI LILLY COM 532457108 456 0 0.00 355 33.58 0.0933
2024-02-05 2023-12-31 13F ELI LILLY COM 532457108 456 -7 -1.51 266 6.85 0.0767
2023-10-25 2023-09-30 13F ELI LILLY COM 532457108 463 463 249 0.0787
2023-05-04 2023-03-31 13F Lilly Eli &co Com Equity 532457108 0 -2,120 -100.00 0 -100.00
2023-02-02 2022-12-31 13F Lilly Eli &co Com Equity 532457108 2,120 -21 -0.98 776 11.99 0.2700
2022-11-14 2022-09-30 13F Lilly Eli &co Com Equity 532457108 2,141 31 1.47 692 1.17 0.2461
2022-08-12 2022-06-30 13F Lilly Eli &co Com Common Stock 532457108 2,110 64 3.13 684 16.72 0.2350
2022-05-16 2022-03-31 13F Lilly Eli &co Com Common Stock 532457108 2,046 19 0.94 586 4.64 0.1749
2022-02-14 2021-12-31 13F Lilly Eli &co Com Common Stock 532457108 2,027 83 4.27 560 24.72 0.1427
2021-11-16 2021-09-30 13F Lilly Eli &co Com Equity 532457108 1,944 -1,571 -44.69 449 -44.36 0.1087
2021-08-13 2021-06-30 13F Lilly Eli &co Com Equity 532457108 3,515 3,515 807 0.1820
2021-05-17 2021-03-31 13F Lilly Eli &co Com Common Stock 532457108 0 -4,855 -100.00 0 -100.00
2021-02-18 2020-12-31 13F/A-1 Lilly Eli &co Com Common Stock 532457108 4,855 994 25.74 820 43.36 0.2454
2021-02-12 2020-12-31 13F Lilly Eli &co Com Common Stock 532457108 1,013 -2,848 820 243,810.3393
2020-11-16 2020-09-30 13F Lilly Eli &co Com Common Stock 532457108 3,861 3,861 -20.47 572 -30.24 0.2161
2020-05-13 2020-03-31 13F Lilly Eli &co Com Common Stock 532457108 0 -7,354 -100.00 0 -100.00
2020-01-24 2019-12-31 13F Lilly Eli &co Com Common Stock 532457108 7,354 7,354 967 0.3935
2019-08-08 2019-06-30 13F Lilly Eli &co Com Equity 532457108 0 -600 -100.00 0 -100.00
2019-05-15 2019-03-31 13F Lilly Eli &co Com Equity 532457108 600 -84 -12.28 78 -1.27 0.0336
2019-02-14 2018-12-31 13F Lilly Eli &co Com COM 532457108 684 -3,442 -83.42 79 -82.17 0.0542
2018-11-15 2018-09-30 13F Lilly Eli &co Com Equity 532457108 4,126 -200 -4.62 443 20.05 0.1547
2018-08-14 2018-06-30 13F Lilly Eli &co Com Equity 532457108 4,326 78 1.84 369 12.16 0.1346
2018-05-15 2018-03-31 13F Lilly Eli &co Com Equity 532457108 4,248 -210 -4.71 329 -12.73 0.1130
2018-02-13 2017-12-31 13F Lilly Eli &co Com Equity 532457108 4,458 0 0.00 377 -1.05 0.1407
2017-11-14 2017-09-30 13F Lilly Eli &co Com Equity 532457108 4,458 0 0.00 381 3.81 0.1579
2017-08-15 2017-06-30 13F Lilly Eli &co Com Equity 532457108 4,458 216 5.09 367 2.80 0.1653
2017-05-08 2017-03-31 13F Lilly Eli &co Com Equity 532457108 4,242 -36 -0.84 357 13.33 0.1814
2017-02-14 2016-12-31 13F Lilly Eli &co Com Equity 532457108 4,278 4,278 315 0.1638
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.